Genetic analysis identifies DDR2 as a novel gene affecting bone mineral density and osteoporotic fractures in Chinese

Yan Guo1, Tie-Lin Yang1, Shan-Shan Dong1

  • 1Key Laboratory of Biomedical Information Engineering of Ministry of Education, and Institute of Molecular Genetics, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, P. R. China.

Plos One
|February 7, 2015
PubMed

Insights

Genetic variations in the DDR2 gene are linked to bone mineral density (BMD) and osteoporosis risk in the Chinese population. These findings suggest DDR2 as a potential target for osteoporosis research, with observed ethnic differences warranting further investigation.

Area of Science:

  • Genetics
  • Bone Biology
  • Osteoporosis Research

Background:

  • The DDR2 gene plays a crucial role in bone cell differentiation and maturation.
  • Genetic variations in DDR2 may influence bone mineral density (BMD) and osteoporosis susceptibility.
  • Previous studies have not fully elucidated the specific genetic variants associated with these effects.

Purpose of the Study:

  • To investigate the association between genetic variants in the DDR2 gene and BMD.
  • To examine the relationship between DDR2 genetic variants and the risk of hip fractures.
  • To explore potential ethnic differences in these associations.

Main Methods:

  • Genotyping of 28 single nucleotide polymorphisms (SNPs) in the DDR2 gene.
  • Association analyses were performed in three cohorts: 1,300 Chinese Han subjects, 700 Chinese Han subjects (including fracture cases and controls), and 2,286 US white subjects.
  • Haplotype and expression quantitative trait loci (eQTL) analyses were conducted.

Main Results:

  • Three DDR2 SNPs (rs7521233, rs7553831, rs6697469) were significantly associated with hip BMD in the Chinese population.
  • SNP rs6697469 was also associated with an increased risk of hip fractures in Chinese individuals.
  • No significant associations with hip BMD were observed in the US white population.
  • eQTL analyses indicated that BMD-associated SNPs influenced DDR2 mRNA expression in Chinese subjects.

Conclusions:

  • The DDR2 gene is a potential candidate gene for osteoporosis in the Chinese population.
  • Genetic variants in DDR2 are associated with BMD and fracture risk in Chinese individuals.
  • Significant ethnic differences exist in the association between DDR2 variants and BMD, highlighting the need for ethnicity-specific genetic studies.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
72
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
20.3K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
132
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
4.3K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
98